Following the successful Change Notification (CN) approval from the World Health Organization (WHO), Colexa Biosensor Limited, a subsidiary of Codix Group, is now licensed to package a WHO-Prequalified Rapid Diagnostic Test kit at its factory in Nigeria. This groundbreaking approval enables Colex
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp